• University of Macau Featured PhD Programmes
  • University of Birmingham Featured PhD Programmes
  • University of Stirling Featured PhD Programmes
  • University of Manchester Featured PhD Programmes
  • Northumbria University Featured PhD Programmes
  • University of Exeter Featured PhD Programmes
  • University of Surrey Featured PhD Programmes
King’s College London Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Southampton Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
University of Warwick Featured PhD Programmes

MRes: Novel kinase inhibitors as anti tumour agents

  • Full or part time
  • Application Deadline
    Friday, August 31, 2018
  • Funded PhD Project (Students Worldwide)
    Funded PhD Project (Students Worldwide)

About This PhD Project

Project Description

The project will develop novel inhibitors of mTOR kinase and other related cancer chemotherapy targets, extending our recent published work on bridged bicyclic morpholines (Chemical Communications 2013, 49, 8931). Biological evaluation of these compounds using a combination of cell-free and cell-based assays will be employed to determine the extent of mTOR pathway modulation in normal and cancer cells. The work will be focused on synthetic organic chemistry. The successful candidate will have a degree in chemistry or pharmacy, excellent practical skills and a strong interest in synthetic and medicinal chemistry.

This project is only for one year.

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully




Let us know you agree to cookies

We use cookies to give you the best online experience. By continuing, we'll assume that you're happy to receive all cookies on this website. To read our privacy policy click here

Ok